Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-36.44	-10.66	-7.81
Graham Fair Price	-65.41	0.72	2.07
PEG	6.15	0.29	-0.27
Price/Book	328.43	9.83	-2.29
Price/Cash Flow	17.99	-7.18	-8.75
Prices/Earnings	11.60	-6.46	-7.31
Price/Sales	-37.92	4.57	7.37
Price/FCF	17.99	-7.18	-8.75
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-16.89	0.03	-0.04
Operating Margin	39.30	-0.54	-0.89
ROA	20.64	-0.01	-0.02
ROE	0.08	-0.38	384.63
ROIC	0.16	-0.29	77.88
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.11	0.22	-48.56
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.41	0.33	-19.28
EPS QOQ	-0.27	0.22	-16.72
FCF QOQ	-0.35	0.16	-52.29
Revenue QOQ	0.42	0.10	-75.64
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	< 0.005	100.00
Days Sales Outstanding (DSO)	79.53	77.27	-2.84
Inventory Turnover	0.00	53302000.00	100.00
Debt/Capitalization	-0.73	0.75	1.61
Quick Ratio	2.84	2.73	-3.69
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	-1.56	0.25	-84.29
Cash	2.03	1.68	-17.52
Capex	-0.34	-0.20	40.51
Free Cash Flow	-0.41	-0.34	17.91
Revenue	0.49	0.53	8.43
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.98	2.93	-1.86
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	4.85	7.00	44.14
Naive Interpretation	Member

06 - Financial Health · Bad

Rating